Apollo Ingredients will hold a board meeting on September 22, 2026, to evaluate sustainability initiatives and potential expansion into the healthcare sector. The company previously operated under the name Indsoya Limited.

The Board of Directors scheduled the meeting for 4:00 pm at its registered office in Vasai, Maharashtra. The agenda focuses on strategic growth avenues rather than financial results, indicating a phase of operational planning.

Strategic Agenda Items

The board has listed three primary matters for discussion during the session:

• Environmental Product Declarations (EPDs): The board will discuss implementing EPDs across the value chain to enhance sustainability credentials and market competitiveness.
• Government Contracts: Directors will explore prospects for participating in government tenders to identify new business opportunities.
• Healthcare Diversification: The meeting will address opportunities for backward integration within the healthcare industry to strengthen business capabilities.

Regulatory Context

The intimation was issued pursuant to Regulation 29(1) (a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ayushi Agrawal, Company Secretary and Compliance Officer, signed the notice dated September 17, 2026.

The company maintains manufacturing units in Shrirampur MIDC, Ahmednagar, alongside its registered office in Thane, Palghar.

Apollo Ingredients Limited reported a strong financial turnaround in its standalone unaudited results for the quarter ended June 30, 2026, posting a net profit of ₹121.62 lakh compared to a net loss of ₹8.77 lakh in the same period of the previous year. The company’s revenue from operations stood at ₹626.87 lakh, while total comprehensive income mirrored the net profit figure at ₹121.62 lakh. This performance signals a recovery in operational efficiency and profitability for the ingredients manufacturer.

The financial statements were reviewed by the Audit Committee and approved by the Board of Directors at a meeting held on August 10, 2026. In compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company filed the detailed results with the stock exchanges. The statutory auditors carried out a limited review of the financial results and expressed an unqualified opinion. The full format of the results is available on the Bombay Stock Exchange website and the company’s official portal.

Key Financial Metrics

Note: Figures are in ₹ lakh unless otherwise specified. Previous year figures have been regrouped where necessary.

What the Numbers Show

The most notable aspect of the quarter is the contribution of other income, which stood at ₹300.39 lakh, significantly higher than the operating revenue of ₹626.87 lakh. While the core operations generated substantial revenue, the net profit of ₹121.62 lakh suggests that other income played a pivotal role in driving the bottom-line turnaround. In the preceding quarter (Q4FY26), other income was ₹98.37 lakh against revenue of ₹107.91 lakh, indicating a seasonal or specific event-driven spike in non-operating gains in Q1FY26. Investors should monitor whether this level of other income is sustainable or if it stems from one-off events.

The equity share capital remained stable at ₹520 lakh, with a face value of ₹10 per share. The company previously operated under the name Indsoya Limited. The results reflect a consolidated view of the standalone entity, as no subsidiary data was provided in the extract. The turnaround from a loss position in Q1FY25 to a profitable quarter highlights improved cost management or favorable external factors contributing to the current fiscal year's performance.